← Back to Sectors

Top Healthcare Companies

Explore econometric models and financial health benchmarks for the leading Healthcare companies.

Median Rev Growth

6.7%

Median R&D Effort

3.5%

Companies Tracked

50

Company Leaderboard

Unitedhealth Group Incorporated

UNH
FY Rev: $505B

Unitedhealth Group Incorporated's latest quarterly revenue is $112B for the period ending 2026-06-30.

Mckesson Corporation

MCK
FY Rev: $464B

Mckesson Corporation's latest quarterly revenue is $105B for the period ending 2026-06-30.

Cencora, Inc.

COR
FY Rev: $354B

Cencora, Inc.'s latest quarterly revenue is $84.8B for the period ending 2026-06-30.

Cardinal Health, Inc.

CAH
FY Rev: $245B

Cardinal Health, Inc. has SEC quarterly revenue data through 2025-12-31.

The Cigna Group

CI
FY Rev: $240B

The Cigna Group's latest quarterly revenue is $71.7B for the period ending 2026-06-30.

Centene Corporation

CNC
FY Rev: $215B

Centene Corporation's latest quarterly revenue is $44.4B for the period ending 2026-06-30.

Elevance Health, Inc.

ELV
FY Rev: $214B

Elevance Health, Inc.'s latest quarterly revenue is $50.5B for the period ending 2026-06-30.

Eli Lilly and Company

LLY
FY Rev: $118B

Eli Lilly and Company's latest quarterly revenue is $23.0B for the period ending 2026-06-30.

Johnson & Johnson

JNJ
FY Rev: $108B

Johnson & Johnson's latest quarterly revenue is $25.3B for the period ending 2026-06-28.

Abbvie Inc.

ABBV
FY Rev: $67B

Abbvie Inc.'s latest quarterly revenue is $17.0B for the period ending 2026-06-30.

Merck & Co., Inc.

MRK
FY Rev: $65B

Merck & Co., Inc.'s latest quarterly revenue is $16.6B for the period ending 2026-06-30.

Pfizer Inc

PFE
FY Rev: $56B

Pfizer Inc's latest quarterly revenue is $15.0B for the period ending 2026-06-28.

Abbott Laboratories

ABT
FY Rev: $48B

Abbott Laboratories's latest quarterly revenue is $11.2B for the period ending 2026-03-31.

Thermo Fisher Scientific Inc.

TMO
FY Rev: $48B

Thermo Fisher Scientific Inc.'s latest quarterly revenue is $12.0B for the period ending 2026-06-27.

Bristol-Myers Squibb Company

BMY
FY Rev: $45B

Bristol-Myers Squibb Company's latest quarterly revenue is $13.0B for the period ending 2026-06-30.

Medtronic Plc

MDT
FY Rev: $42B

Medtronic Plc's latest quarterly revenue is $9.8B for the period ending 2026-07-31.

Amgen Inc

AMGN
FY Rev: $40B

Amgen Inc's latest quarterly revenue is $10.1B for the period ending 2026-06-30.

Gilead Sciences, Inc.

GILD
FY Rev: $29B

Gilead Sciences, Inc.'s latest quarterly revenue is $7.8B for the period ending 2026-06-30.

Stryker Corp

SYK
FY Rev: $28B

Stryker Corp's latest quarterly revenue is $6.6B for the period ending 2026-06-30.

Boston Scientific Corporation

BSX
FY Rev: $25B

Boston Scientific Corporation's latest quarterly revenue is $5.4B for the period ending 2026-06-30.

Danaher Corporation

DHR
FY Rev: $24B

Danaher Corporation's latest quarterly revenue is $6.3B for the period ending 2026-06-26.

Becton, Dickinson and Company

BDX
FY Rev: $22B

Becton, Dickinson and Company's latest quarterly revenue is $5.0B for the period ending 2026-06-30.

Ge Healthcare Technologies Inc.

GEHC
FY Rev: $21B

Ge Healthcare Technologies Inc.'s latest quarterly revenue is $5.1B for the period ending 2026-03-31.

Vertex Pharmaceuticals Inc / Ma

VRTX
FY Rev: $20B

Vertex Pharmaceuticals Inc / Ma's latest quarterly revenue is $3.3B for the period ending 2026-06-30.

Iqvia Holdings Inc.

IQV
FY Rev: $18B

Iqvia Holdings Inc.'s latest quarterly revenue is $4.2B for the period ending 2026-03-31.

Baxter International Inc.

BAX
FY Rev: $16B

Baxter International Inc.'s latest quarterly revenue is $3.0B for the period ending 2026-06-30.

Regeneron Pharmaceuticals, Inc.

REGN
FY Rev: $16B

Regeneron Pharmaceuticals, Inc.'s latest quarterly revenue is $4.3B for the period ending 2026-06-30.

Kenvue Inc.

KVUE
FY Rev: $15B

Kenvue Inc.'s latest quarterly revenue is $4.0B for the period ending 2026-06-28.

Viatris Inc.

VTRS
FY Rev: $14B

Viatris Inc.'s latest quarterly revenue is $3.7B for the period ending 2026-06-30.

Henry Schein, Inc.

HSIC
FY Rev: $13B

Henry Schein, Inc.'s latest quarterly revenue is $3.5B for the period ending 2026-06-27.

Intuitive Surgical, Inc.

ISRG
FY Rev: $13B

Intuitive Surgical, Inc.'s latest quarterly revenue is $2.9B for the period ending 2026-06-30.

Quest Diagnostics Incorporated

DGX
FY Rev: $12B

Quest Diagnostics Incorporated's latest quarterly revenue is $3.0B for the period ending 2026-06-30.

Biogen Inc.

BIIB
FY Rev: $10B

Biogen Inc.'s latest quarterly revenue is $2.5B for the period ending 2026-03-31.

Agilent Technologies, Inc.

A
FY Rev: $8.6B

Agilent Technologies, Inc.'s latest quarterly revenue is $1.9B for the period ending 2026-07-31.

Edwards Lifesciences Corporation

EW
FY Rev: $7.8B

Edwards Lifesciences Corporation's latest quarterly revenue is $1.7B for the period ending 2026-06-30.

Resmed Inc.

RMD
FY Rev: $6.4B

Resmed Inc.'s latest quarterly revenue is $1.5B for the period ending 2026-06-30.

Steris Plc

STE
FY Rev: $6.4B

Steris Plc's latest quarterly revenue is $1.5B for the period ending 2026-06-30.

Dexcom, Inc.

DXCM
FY Rev: $5.9B

Dexcom, Inc.'s latest quarterly revenue is $1.3B for the period ending 2026-06-30.

Humana Inc.

HUM
FY Rev: $5.8B

Humana Inc.'s latest quarterly revenue is $1.7B for the period ending 2026-03-31.

Incyte Corporation

INCY
FY Rev: $5.6B

Incyte Corporation's latest quarterly revenue is $1.3B for the period ending 2026-03-31.

Idexx Laboratories Inc /De

IDXX
FY Rev: $4.8B

Idexx Laboratories Inc /De's latest quarterly revenue is $1.2B for the period ending 2026-06-30.

Waters Corporation

WAT
FY Rev: $4.6B

Waters Corporation has SEC quarterly revenue data through 2026-07-04.

West Pharmaceutical Services, Inc.

WST
FY Rev: $4.5B

West Pharmaceutical Services, Inc.'s latest quarterly revenue is $872M for the period ending 2026-06-30.

Mettler-Toledo International Inc.

MTD
FY Rev: $4.4B

Mettler-Toledo International Inc.'s latest quarterly revenue is $1.0B for the period ending 2026-06-30.

The Cooper Companies, Inc.

COO
FY Rev: $4.4B

The Cooper Companies, Inc.'s latest quarterly revenue is $1.1B for the period ending 2026-07-31.

Hologic Inc

HOLX
FY Rev: $4.1B

Hologic Inc has SEC quarterly revenue data through 2025-12-27.

Insulet Corporation

PODD
FY Rev: $4.1B

Insulet Corporation's latest quarterly revenue is $802M for the period ending 2026-06-30.

Align Technology, inc.

ALGN
FY Rev: $4.1B

Align Technology, inc.'s latest quarterly revenue is $1.1B for the period ending 2026-06-30.

Charles River Laboratories International, Inc.

CRL
FY Rev: $3.8B

Charles River Laboratories International, Inc.'s latest quarterly revenue is $1.0B for the period ending 2026-06-27.

Bio-Techne Corporation

TECH
FY Rev: $1.2B

Bio-Techne Corporation's latest quarterly revenue is $321M for the period ending 2026-06-30.